Study of Pegcetacoplan (APL-2) Therapy in Patients With Geographic Atrophy
Completed · Phase 2 · Has a placebo group
Conditions studied: Geographic Atrophy
In brief
The primary objectives of the study are to assess the safety, tolerability and evidence of activity of multiple intravitreal (IVT) injections of pegcetacoplan in subjects with Geographic Atrophy associated with Age-Related Macular Degeneration (AMD).
Key facts
- Study ID
- NCT02503332
- Run by
- Apellis Pharmaceuticals, Inc.
- People needed
- 246
- Starts
- 2015-09-24
- Expected to finish
- 2018-01-17
- Last updated by the study team
- 2020-10-06
Who can join
Age: 50 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Retina Speciality Institute — Mobile, Alabama, United States
- Retinal Research Institute — Phoenix, Arizona, United States
- Retina Vitreous Asociates Mdical Goup — Beverly Hills, California, United States
- The Gavin Herbert Eye Institute/UC Irvine — Irvine, California, United States
- University of Southern California - USC Eye Institute — Los Angeles, California, United States
- Byers Eye Institute at Stanford, Stanford School of Medicine — Palo Alto, California, United States
- New England Retina Associates — New London, Connecticut, United States
- Florida Eye Microsurgical Institute, Inc. — Boynton Beach, Florida, United States
- Retina Health Center — Fort Myers, Florida, United States
- Bascom Palmer Eye Institute — Miami, Florida, United States
- South East Retina — Augusta, Georgia, United States
- Illinois Retina Associates — Harvey, Illinois, United States
- Midwest Eye Institute — Indianapolis, Indiana, United States
- Elman Research — Baltimore, Maryland, United States
- Ophthalmic Consultants of Boston — Boston, Massachusetts, United States
- Associated Retinal Consultants PC — Grand Rapids, Michigan, United States
- Associated Retinal Consultants, PC — Traverse City, Michigan, United States
- Mayo Clinic — Rochester, Minnesota, United States
- Eyesight Opthalmic Services PA — Portsmouth, New Hampshire, United States
- Vitreous Retina Macula Consultants of New York — New York, New York, United States
- Charlotte Eye Ear Nose and Throat Associates — Charlotte, North Carolina, United States
- Duke University, Duke Eye Center — Durham, North Carolina, United States
- Charlotte Eye Ear Nose and Throat Associates — Statesville, North Carolina, United States
- Cleveland Clinic Foundation/ Cole Eye Institute — Cleveland, Ohio, United States
- Retina Associates of Cleveland — Cleveland, Ohio, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.